ARCHIVES

Phase III Regorafenib Trial Meets PFS Primary Endpoint

This article is from The Cancer Letter archive.

Vol. 35 No. 6 | June 29, 2012

Download PDF Visit The Full Archive

Related Articles

RFPs Available, Contract Awards, Sole Source Negotiations

June 25, 1976

Some Long-Term Survivors At Higher Risk Of Stroke

November 24, 2006

In Brief: Walter Lawrence, Reginald Ho Lead ACS; Henderson To Leave Dana-Farber for UCSF

November 22, 1991

Committee Approves Concepts For Studies In Special Populations

December 11, 1987

Lung Cancer Clinical Trials Cost-Effective Alternative

October 31, 2003

In Brief: Reginald Ho Assumes ACS Presidency; Board Calls On NCI To Fully Fund ASSIST Program

November 13, 1992